Philip Toleikis
Corporate Officer/Principal bei Medway Working Group
Vermögen: 2 Mio $ am 30.04.2024
Profil
Philip M.
Toleikis is a Member of the Medway Working Group.
He previously worked as the Director & Chief Technology Officer at Sernova Corp.
from 2023 to 2024 and as the VP-Pharmacology, Research & Development at Angiotech Pharmaceuticals, Inc. in 2006.
Dr. Toleikis holds a doctorate degree from the University of British Columbia, a graduate degree from the University of Michigan, and an undergraduate degree from the University of Vermont.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SERNOVA CORP.
1,74% | 25.04.2023 | 5 273 598 ( 1,74% ) | 2 Mio $ | 30.04.2024 |
Aktive Positionen von Philip Toleikis
| Unternehmen | Position | Beginn |
|---|---|---|
| Medway Working Group | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Philip Toleikis
| Unternehmen | Position | Ende |
|---|---|---|
| SERNOVA CORP. | Vorstandsvorsitzender | 05.09.2023 |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 |
Ausbildung von Philip Toleikis
| University of British Columbia | Doctorate Degree |
| University of Michigan | Graduate Degree |
| University of Vermont | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SERNOVA CORP. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
| Medway Working Group |
